(1)
Mohammad Haider Khan; Muhammad Syed Ali Hamza. Resmetirom in Fatty Liver Disease: A Promising Step Ahead in Metabolic Dysfunction-Associated Steatotic Liver Disease Treatment. J Pak Med Assoc 2026, 76, 1002-1002.